Figure 3.
Change from baseline in percent body fat z score (%BFZ) and fat-free mass z score (FFMZ) among subjects treated with peginterferonα2a for 48 weeks. Error bars indicate 95% confidence interval. The shaded regions indicate time on peginterferonα2a. Results are from a generalized linear model, adjusted for baseline age and sex.